Albany, US, 2017-Oct-13 — /EPR Network/ —The global nanoemulsion market is likely to grow at over 9% CAGR and reach nearly US$ 15 bn in revenues by 2025. Leading players in the global nanoemulsion market are focusing on emerging markets to consolidate their position. A number of factors are likely to influence the growth of the global nanoemulsion market. These insights are according to a research report added to the database of Market Research Hub (MRH). The report is titled “Nanoemulsion Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”.
Request For Free Sample Report: https://www.marketresearchhub.com/enquiry.php?type=S&repid=1339668
According to the report, leading players in the market have a strong pipeline of vaccines against various medicines. Growing demand for target specific drug delivery systems and new product launches is also anticipated to fuel the growth of the market during the forecast period.
The market is also influenced by macroeconomic factors, including increase in spending on healthcare. Developing countries around the world are revamping their healthcare budgets, and on account of this, the nanoemulsion market is also benefiting. The report profiles the key players in the market including Mitsubishi Tanabe Pharma Corporation, GlaxoSmithKline plc, AbbVie Inc., Fresenius Kabi AG, Ltd., Kaken Pharmaceutical Co., AstraZeneca Inc., Allergan plc, Novartis AG, Sanofi, and B. Braun Melsungen AG.
The report offers detailed segmentation on the basis of drug type. The key segments include immunosuppressants, antiretroviral, vasodilators, antimicrobials, steroids, NSAIDs, and anesthetics. On account of increasing use of nanoemulsion formulation in topical administration, demand for NSAID is increasing. This segment is likely to witness steady growth over the forecast period, and is likely to rake in nearly US$ 2.5 bn by the end of forecast period.
North America remains the most lucrative market for nanoemulsions globally. According to the report, demand for nanoemulsions in North America will be dominated by strong uptake in the U.S. The large biotechnology and pharmaceutical industry in North America will continue to provide sustained growth opportunities to manufacturers.
Europe is another lucrative market for nanoemulsions globally. The demand for nanoemulsions in Europe is driven by the well-established pharmaceutical industry in the continent. The total sales of nanoemulsions in Europe are likely to surpass US$ 5 bn by end of 2025.
In addition to Europe and North America, Asia Pacific excluding Japan (APEJ) market is likely to emerge as an attractive market. Increase in government support for healthcare funding is likely to provide impetus to the growth of the market.
Enquire About This Report: https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1339668
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
90 State Street,
Albany, NY 12207,